Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Post-Marketing Safety Surveillance Registry of Enbrel (Etanercept) for Treatment of Psoriasis

NCT00322439 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00322439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Post-Marketing Safety Surveillance Registry of Enbrel (Etanercept) for Treatment of Psoriasis
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
May 1, 2006
Completion date
February 8, 2013
Enrollment
2,511 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis